[1]
« Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach », Can Hematol Today, vol. 5, nᵒ 2, p. 26–36, sept. 2026, doi: 10.58931/cht.2026.5290.